MENU SEARCH
TOP NEWS
  • Telangana releases Rs 500 cr for 'Dalit Bandhu' in Huzurabad
  • PM Modi gives 5-point agenda for maritime security at UNSC
  • 'Delhi HC at less than 50% in week': SC criticises Centre's appointment delays
  • Kerala's Covid TPR continues to hover around 13%
  • SC says judicial officers must feel safe, asks HC to monitor judge death probe
  • Attacks in Europe could be outcome of terror groups from Afghanistan
  • Trinamool trying to gain political mileage from 'mock troubles' in Tripura: BJP
  • 'Utterly mischievous', Madras HC dismisses PIL against CM Stalin
  • Congress stages protest against suspension of Rahul's Twitter account
  • Widespread, rapid & intensifying: IPCC warning on climate change
  • PM pays tribute to 'greats' who took part in Quit India Movement
  • Student, minor held for posting lewd messages in study group
  • Modi condemns attack on PM of St. Vincent and the Grenadines
  • Man booked for remarks against Mulayam, Akhilesh
  • Delhi Airport adjudged 'Best Airport' in India, Central Asia
  • 'Satellite communication to be next (r)evolution in broadband space'
  • Future Generali sets up Covid-19 ward for mothers/new born in Mumbai
  • India smartphone market set to bounce back in Q3: Report
  • Digital transactions grow 80% in last 250 days in India: Report
Tags: India | Zydus | vaccine | Centre | HC

Statutory Nod for Zydus Cadila Vax for 12-18 Age-group Soon, Centre to HC

Statutory Nod for Zydus Cadila Vax for 12-18 Age-group Soon, Centre to HC

Friday, 16 July 2021

New Delhi: The Centre has informed the Delhi High Court that Zydus Cadila, which is developing DNA vaccines has concluded its clinical trial for the age group of 12 to 18.

The affidavit filed by under secretary, Department of Health and Family Welfare, said: "It is submitted that Zydus Cadila, which is developing DNA vaccines has concluded its clinical trial for between the age group of 12 to 18 and subject to the statutory permissions, the same may be available in near future for children of the age group of 12 to 18 years of age".

The affidavit added that May 1, onwards under the liberalized pricing and accelerated national Covid vaccination strategy, all citizens above the age of 18 years including parents of children who are residing ion Delhi are already eligible for Covid-19 vaccination.

The Centre said the vaccination is its top most priority and all efforts are being made to achieve " an objective of 100 percent vaccination in the shortest time possible keeping the available resources in mind and availability of vaccine doses into consideration".

The Centre filed this affidavit in response to the plea, filed by Tia Gupta through advocate Bihu Sharma demanding for immediate vaccination of children between the ages of 12-17 in the city, and also prioritizing of vaccination for parents having children up to 17 years of age.

In June last week, the Centre had informed the Supreme Court that Zydus Cadila, has concluded its clinical trials for the 12 to 18 age group, and the vaccine may be available in near future, subject to the statutory permissions

Today, according to Sharma, Delhi High Court Chief Justice asked the central government to frame a policy for children's vaccination expeditiously.

The plea contended that data from across the country, including Delhi, has revealed that between April-May, the number of reported cases of children infected and suffering Covid-19 has risen tremendously.

On May 28, a bench comprising Chief Justice D N Patel and justice Jyoti Singh had issued notice to Centre and Delhi government on the petition. The plea contended that it is pertinent the vaccine policy against Covid-19 has failed to factor-in children or parents of children, who are a vulnerable section of society, for vaccination against the deadly virus. The plea added that the evidence that unvaccinated children are more likely to develop a new, more powerful Covid-19 strain, is reflected in the prevalent 'second wave', which has infected many more children than the 'first wave' last year.
 

© 2021 IANS. All rights reserved.

Nation
The Centre has informed the Delhi High Court that Zydus Cadila, which is developing DNA vaccines has concluded its clinical trial for the age group of 12 to 18.
India, Zydus, vaccine, Centre, HC
416
2021-12-16
Friday, 16 July 2021
Newsmax Media, Inc.
 

You are browsing the Beta Experience of Newsmax India. We hope you enjoy your time here.

Newsmax and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax India are trademarks of Newsmax Media, Inc.

NEWSMAX.IN
Real News for Real People
© Newsmax Media, Inc.
All Rights Reserved